Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study.
Hughes, P. M.
Masoli, Jane A.
Mujica Mota, R. E.
Henley, W. E.
JournalThe journals of gerontology. Series A, Biological sciences and medical sciences
RightsArchived with thanks to The journals of gerontology. Series A, Biological sciences and medical sciences. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
MetadataShow full item record
There is limited evidence on statin risk and effectiveness for patients aged 80+. We estimated risk of recurrent myocardial infarction, muscle-related and other adverse events, and statin-related incremental costs in "real-world" older patients treated with statins versus no statins.